In8bio Shares Outstanding History (INAB)
In8bio reported 9.8M shares outstanding at the end of fiscal 2025.
View full In8bio company overviewIn8bio annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 9.8M | 7.4M | +304.22% |
| 2024 | 2024-12-31 | 2.4M | −40.9M | −94.42% |
| 2023 | 2023-12-31 | 43.3M | 18.7M | +76.36% |
| 2022 | 2022-12-31 | 24.5M | 5.8M | +30.69% |
| 2021 | 2021-12-31 | 18.8M | 15.0M | +398.91% |
| 2020 | 2020-12-31 | 3.8M | — | — |
In8bio quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 9.9M | 5.8M | +141.61% |
| Q1 2026 | 2026-03-31 | 9.8M | −71.4M | −87.88% |
| Q4 2025 | 2025-12-31 | 9.8M | −62.7M | −86.53% |
| Q3 2025 | 2025-09-30 | 4.6M | −42.2M | −90.19% |
| Q2 2025 | 2025-06-30 | 4.1M | −42.4M | −91.22% |
| Q1 2025 | 2025-03-31 | 81.3M | 38.0M | +87.72% |
| Q4 2024 | 2024-12-31 | 72.5M | 40.5M | +126.68% |
| Q3 2024 | 2024-09-30 | 46.8M | 16.2M | +52.87% |
| Q2 2024 | 2024-06-30 | 46.4M | 21.5M | +86.03% |
| Q4 2023 | 2023-12-31 | 43.3M | 18.7M | +76.36% |
| Q3 2023 | 2023-09-30 | 32.0M | 7.5M | +30.50% |
| Q2 2023 | 2023-06-30 | 30.6M | 11.8M | +62.47% |
| Q1 2023 | 2023-03-31 | 25.0M | 6.1M | +32.68% |
| Q4 2022 | 2022-12-31 | 24.5M | 5.8M | +30.69% |
| Q3 2022 | 2022-09-30 | 24.5M | 5.7M | +30.65% |
| Q2 2022 | 2022-06-30 | 18.8M | 15.1M | +400.43% |
| Q1 2022 | 2022-03-31 | 18.8M | 15.0M | +399.73% |
| Q4 2021 | 2021-12-31 | 18.8M | — | — |
| Q3 2021 | 2021-09-30 | 18.8M | — | — |
| Q2 2021 | 2021-06-30 | 3.8M | — | — |
| Q4 2020 | 2020-12-31 | 3.8M | — | — |
In8bio shares outstanding trends
Over the last five reported fiscal years, In8bio's shares outstanding moved from 3.8M to 9.8M, a change of 6.0M. The latest reported quarter, Q2 2026, shows 9.9M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review In8bio filings at SEC.gov ↗